DUBLIN--(BUSINESS WIRE)--HiberGene Diagnostics, a company focused on the application of molecular technology to infectious disease testing, has made its first product sales, and has secured a number of distributors across Europe, Middle East and Africa
HiberGene made its first product shipments in December 2015, and has appointed distributors in a number of countries across Europe, Middle East and Africa. These territories include Germany, Austria, Spain, Portugal, Ireland, Poland, Hungary, Sweden, Denmark, Norway, Finland, Turkey, Israel and South Africa. HiberGene is also in discussion with potential distributors in Italy, UK, France, Belgium, Netherlands, Greece, China, India, Saudi Arabia, Australia, South Korea, Taiwan, Singapore and Malaysia.
HiberGene made its first product shipments in December 2015, and has appointed distributors in a number of countries across Europe, Middle East and Africa. These territories include Germany, Austria, Spain, Portugal, Ireland, Poland, Hungary, Sweden, Denmark, Norway, Finland, Turkey, Israel and South Africa. HiberGene is also in discussion with potential distributors in Italy, UK, France, Belgium, Netherlands, Greece, China, India, Saudi Arabia, Australia, South Korea, Taiwan, Singapore and Malaysia.
